News and views on the clinical trials industry
Featured Chart
May
In-depth Coverage
Sites worldwide rate top CROs
A new CenterWatch survey of investigative sites around the world shows CROs have continued to
improve their relationships with sites. Three global CROs came out with top rankings: PPD,
Kendle and ICON.
Step-up in FDA audits has sites scrambling to be ready
Sites used to rely on monitors to ensure their compliance. But now, with the FDA ramping up
scrutiny and protocols growing more complex, sites must be responsible for their own quality
assurance and always be audit-ready.
Eye On Human Genome Sciences
A detailed examination at HGS’s drug discovery pipeline.
To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.
April
In-depth Coverage
Liability demands putting sites at risk
Indemnification has emerged as one of the most contentious issues in clinical trial contract
negotiations for private investigative sites. Added to the already high site risk, concerns
could drive investigators out of clinical research.
New recruitment tools abound, but results remain unclear
From trials moving overseas and ads moving online to advances in data mining, the myriad
changes in patient recruitment should be yielding big results. But so far, none is translating
into better enrollment.
Eye On Daiichi Sankyo
A detailed examination at Daiichi Sankyo’s drug discovery pipeline.
To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.
